Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
Maurice J D L van der VorstElisabeth C W NeefjesElisa C ToffoliJolanda E W Oosterling-JansenMarije R VergeerC René LeemansMenno P KooistraJens VoortmanMaurice J D L van der VorstPublished in: BMC cancer (2019)
AKI occurred in 69% of patients with LA-SCCHN undergoing CRT with high-dose cisplatin. Long-term renal function was significantly more impaired in patients with AKI. Hypertension and CINV are significant risk factors. Optimizing prevention strategies for CINV are urgently needed.